ACTRN12612000249853已完成2 期
In Dermatologist or Allergist diagnosed eczema, does use of multi-transient receptor potential modifying compound (MTRPMC) formulation plus placebo compared with no MTRPMC formulation plus placebo improve PO SCORAD
Peter Smith0 个研究点目标入组 20 人开始时间: 2012年2月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Dermatologist or Allergist diagnosed eczema severity moderate-severe
- •Significant impairment of quality of life
- •Need for frequent moisturising and topical steroids
- •Must have indicated a willingness to enter the study
- •Must have read and fully understood a study information form
- •Must have had the opportunity to ask any questions prior to enrolment
- •Must have signed study consent form
排除标准
- •Pregnant or likely to become pregnant
- •People whose primary language is other than English (LOTE)
- •People with a cognitive impairment, an intellectual disability or a mental illness
- •Children and/or young people (ie. <18 years)
- •Any history of reaction or intolerance to MTRPMC formulation
研究者
相似试验
已完成
不适用
A Pilot Study of Topical Honey for the Treatment of EczemaEczemaSkin - Dermatological conditionsACTRN12612000561886Medical Research Institute of New Zealand15
撤回
3 期
Beyond conventional treatment of Atopic eczema in infants: Management By specific prObiOtic strains. A double blind placebo-controlled trial.allergyeczema1000170810014982atopic dermatitisNL-OMON34286Sint Antonius Ziekenhuis120
已完成
不适用
A Randomised Placebo-Controlled Trial to compare Dilute Bleach Baths with Water treatment of Children with Eczema.EczemaBacterial Colonisation of the SkinSkin - Dermatological conditionsInfection - Studies of infection and infectious agentsACTRN12611000260921Dr Michael Herd64
尚未招募
不适用
A Study On Drugs Used In Eczema Patients In a Tertiary Care HospitalCTRI/2020/12/029854I
暂停
2 期
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase IIAsthmaRPCEC00000127ational Center of Bioproducts (BIOCEN)120